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NMDA receptor-dependent synaptic modifications,
such as long-term potentiation (LTP) and long-term
depression (LTD), are essential for brain develop-
ment and function. LTD occursmainly by the removal
of AMPA receptors from the postsynaptic mem-
brane, but the underlying molecular mechanisms
remain unclear. Here, we show that activation of cas-
pase-3 via mitochondria is required for LTD and
AMPA receptor internalization in hippocampal
neurons. LTD and AMPA receptor internalization
are blocked by peptide inhibitors of caspase-3
and -9. In hippocampal slices from caspase-3 knock-
out mice, LTD is abolished whereas LTP remains
normal. LTD is also prevented by overexpression of
the anti-apoptotic proteins XIAP or Bcl-xL, and by
a mutant Akt1 protein that is resistant to caspase-3
proteolysis. NMDA receptor stimulation that induces
LTD transiently activates caspase-3 in dendrites,
without causing cell death. These data indicate an
unexpected causal link between the molecular
mechanisms of apoptosis and LTD.
INTRODUCTION
Synaptic plasticity is a crucial process that modifies synapses
in response to neural activity and experience. Long-lasting
changes in the structure and function of synapses are impor-
tant for CNS development and underlie information storage
in the brain. LTP and LTD are long-lasting modifications of
synapses, particularly well-studied in the CA1 region of the
hippocampus. Induction of NMDA receptor-dependent LTD
in CA1 (typically by prolonged low frequency stimulation)
requires Ca2+ influx and the serine/threonine phosphatases
calcineurin/PP2B and PP1 (Malenka and Bear, 2004). Traf-ficking of AMPA receptors to and away from the synapse
determines the abundance of AMPA receptors in the postsyn-
aptic membrane. LTD involves the removal and internalization
of AMPA receptors from synapses (Collingridge et al., 2004;
Malenka and Bear, 2004; Shepherd and Huganir, 2007).
However, the molecular mechanisms underlying LTD, particu-
larly the signaling pathways that couple NMDA receptor stim-
ulation to AMPA receptor internalization, remain largely
unknown. Recent studies have implicated the small GTPase
Rap and protein kinases p38 and GSK3b in LTD (Peineau
et al., 2007; Zhu et al., 2002, 2005).
Caspases are cysteine proteases with well-established func-
tions in the execution of apoptosis. The caspase-9-caspase-3
cascade is activated by proapoptotic molecules such as cyto-
chrome c released from mitochondria, and restrained by cellular
IAPs (inhibitor of apoptosis proteins) (Srinivasula and Ashwell,
2008). The release of cytochrome c from mitochondria is in-
hibited by anti-apoptotic members of the Bcl-2 family of proteins
(such as Bcl-xL) and stimulated by proapoptotic members (such
as BAX and BAK) (Youle and Strasser, 2008).
Interestingly, active caspases are also detected in nonapop-
totic cells. In neurons, mitochondria as well as caspases are
present in dendrites, axons and pre- and postsynaptic terminals,
and there is evidence that caspases can be activated in
dendrites, synaptosomes and growth cones (Campbell and
Holt, 2003; Gilman and Mattson, 2002; Kuo et al., 2006; Williams
et al., 2006; Yuan, 2006). Activated caspases can suppress
synaptic currents and caspase-3 can cleave AMPA receptor
subunit GluR1 in vitro (Chan et al., 1999; Glazner et al., 2000;
Lu et al., 2002). It has been reported that caspases play nona-
poptotic roles in the dendritic pruning of Drosophila neurons
during development (Kuo et al., 2006; Williams et al., 2006), in
the structural remodelling of hippocampal neuron synapses
and Xenopus retinal growth cones (Campbell andHolt, 2003; Gil-
man and Mattson, 2002), and in bird song learning (Huesmann
and Clayton, 2006).
Here, we report that LTD and AMPA receptor internalization
in hippocampal neurons require the activity of caspase-9Cell 141, 859–871, May 28, 2010 ª2010 Elsevier Inc. 859
and caspase-3/7, and can be blocked by overexpression of anti-
apoptotic proteins Bcl-xL and XIAP. Caspase-3 can be tran-
siently activated via the mitochondrial pathway by stimulating
NMDA receptors, without causing cell death; and hippocampal
slices from caspase-3 knockout mice lose specifically their
ability to undergo NMDA receptor-dependent LTD. These find-
ings reveal a critical role of the mitochondrial pathway of cas-
pase activation in synaptic depression.
RESULTS
Caspase Inhibitors DEVD-FMK and LEHD-FMK Block
Hippocampal LTD but Not LTP
We investigated the role of caspases in synaptic plasticity of
Schaffer collateral-CA1 synapses in acute rat hippocampal sli-
ces (3–4 weeks age) (Figure 1). In the first series of experiments,
slices were incubated with cell-permeant caspase inhibitor
peptides: DEVD-FMK (2 mM; an inhibitor with selectivity against
caspases-3, -7, -8); LEHD-FMK (2 mM; a caspase-9-preferring
inhibitor with less potent activity against caspases-6, -8, -2);
YVAD-FMK (5 mM; caspase-1-selective inhibitor); and WEHD-
FMK (200 nM; an inhibitor with preference for caspase-1 and
caspase-8) (Garcia-Calvo et al., 1998; Talanian et al., 1997;
Thornberry et al., 1997). Field excitatory postsynaptic potentials
(fEPSPs) were recorded in area CA1 in response to stimulation of
Schaffer collateral inputs. Bath application of DEVD-FMK
blocked LTD induced by low frequency stimulation (LFS, 1 Hz
for 900 s; 98 ± 2%of baseline in DEVD-FMK; 75 ± 3%of baseline
in control untreated slices, p < 0.01, n = 6, Figure 1A). Impor-
tantly, DEVD-FMK had no effect on LTP induced by tetanus
(100 pulses at 100 Hz, 4 trains; 142 ± 5% of baseline in DEVD-
FMK; 140 ± 5% in control, n = 6, Figure 1B), suggesting that
the peptide was not nonspecifically toxic. A different peptide,
LEHD-FMK, also blocked LTD (97 ± 3%, n = 6, Figure 1C),
without affecting LTP (146 ± 5%, n = 6, Figure 1D). Neither
LTD nor LTP were affected by YVAD-FMK and WEHD-FMK,
similar to the negative control peptide FA-FMK (10 mM; which
should not affect caspase activity) (Figures 1E and 1F; Figures
S1A and S1B available online). In contrast to DEVD- and
LEHD-FMK, bath application of LLY-FMK (5 mM; an inhibitor of
calpain) blocked LTP but not LTD (Figures S1C and S1D). The
sensitivity of LTP to a calpain inhibitor is consistent with
a previous report (Denny et al., 1990).
We measured basal fEPSP slope before and after the applica-
tion of 2 mMDEVD-FMK, and found no significant change after 2
hr exposure (Figure S1E). Thus the caspase inhibitor blocked
LTD without affecting basal synaptic transmission over the
time course of LTD experiments. The fact that DEVD- and
LEHD-FMK specifically blocked LTD without affecting LTP or
basal synaptic strength argues against nonspecific effects of
these peptides on synaptic transmission. DEVD-, LEHD-,
YVAD- and WEHD-FMK show differential potency against indi-
vidual caspases (Garcia-Calvo et al., 1998; Talanian et al.,
1997; Thornberry et al., 1997), and we only observed that
DEVD- and LEHD-FMK, but not YVAD- and WEHD-FMK,
blocked LTD. We thus inferred that a subset of caspases (most
likely caspase-3/7 and caspase-9) is required for induction of
LTD, but not LTP.860 Cell 141, 859–871, May 28, 2010 ª2010 Elsevier Inc.Bcl-xL and XIAP Block LTD but Not LTP in Hippocampal
Slice Cultures
Because the peptide inhibitors show limited selectivity for indi-
vidual caspases, we additionally used molecular approaches
to inhibit caspases. We overexpressed caspase-inhibitor
proteins XIAP, CrmA, and anti-apoptotic protein Bcl-xL in CA1
neurons of organotypic hippocampal slice cultures. XIAP (X
chromosome-linked inhibitory apoptosis protein) is an inhibitor
of caspase-3, -7 and -9 (Deveraux et al., 1998, 1997; Roy
et al., 1997). An N-terminally truncated form of XIAP containing
the third Bir domain of XIAP (XIAP-Bir3) specifically inhibits cas-
pase-9, which is an upstream activator of caspase-3 (Wilkinson
et al., 2004). XIAP-Bir1,2, an XIAP construct containing the
N-terminal two Bir domains, specifically inhibits caspase-3/7
(Chai et al., 2001; Riedl et al., 2001; Sun et al., 2000). Bcl-xL is
an anti-apoptotic Bcl-2 family protein (Kuwana and Newmeyer,
2003) that prevents mitochondrial release of proapoptotic
factors, thereby blocking activation of caspase-9 and caspase-
3. CrmA (a cowpox serpin) is a selective inhibitor of caspase-1,
-5, and -8 (Garcia-Calvo et al., 1998).
CA1 neurons were biolistically transfected with plasmids ex-
pressing Bcl-xL or XIAP (plus GFP as transfection marker) and
recorded in whole-cell patch-clamp mode. LTD or LTP of
Schaffer collateral-CA1 synapses was induced by pairing proto-
cols (see Extended Experimental Procedures). We first analyzed
the effect on basal synaptic transmission by comparing EPSCs
evoked in pairs of transfected and neighboring untransfected
cells in the same slice using the same stimulus position and
intensity. Overexpression of Bcl-xL caused an increase in ampli-
tude of AMPA receptor-mediated EPSCs (Bcl-xL-transfected
cells: 286 ± 18 pA, n = 11; untransfected cells: 147 ± 14 pA,
n = 11, p < 0.01; Figure 2A left). However, Bcl-xL had no effect
on the NMDA receptor-mediated component of EPSC
compared to untransfected cells in the same slices (transfected
cells: 154 ± 9 pA; untransfected: 146 ± 13 pA, p > 0.05;
Figure 2A, right). Overexpression of XIAP-Bir1,2 also caused
an increase in basal AMPA-EPSCs (XIAP-Bir1,2: 316 ± 15 pA,
n = 11; untransfected: 186 ± 15 pA, n = 11, p < 0.01;
Figure 2B), without affecting NMDA-EPSCs (XIAP-Bir1,2: 188 ±
11 pA, n = 11; untransfected: 179 ± 10 pA, n = 11; Figure 2B).
In contrast to Bcl-xL and XIAP-Bir1,2, CrmA did not change
either AMPA-EPSC (CrmA: 202 ± 15 pA, n = 10; untransfected:
210 ± 16 pA, n = 10, p > 0.05; Figure 2C) or NMDA-EPSC ampli-
tudes (CrmA: 164 ± 10 pA; untransfected: 174 ± 11 pA, p > 0.05;
Figure 2C).
Even though they showed a higher basal EPSC, neurons
overexpressing Bcl-xL or XIAP-Bir1,2 were unable to undergo
LTD (Bcl-xL: 97 ± 4%, n = 8; XIAP-Bir1,2: 97 ± 5%, n = 8;
Figure 2D). Similarly, LTD was abolished in CA1 neurons trans-
fected with XIAP-Bir3 (101 ± 3%, n = 8; Figure 2E). In cells
transfected with CrmA, however, LTD was unaffected (66 ±
6%, n = 8; Figure 2E). The induction of LTP was normal in cells
transfected with Bcl-xL, XIAP-Bir1,2 or XIAP-Bir3 (138 ± 5%,
146 ± 5% and 143 ± 8% of baseline, respectively; n = 7 for
each condition; Figure 2F). Control untransfected neurons, as
expected, showed robust LTD (64 ± 4%, n = 6; Figure 2D) as
well as LTP (147 ± 9%, n = 6). The lack of effect on LTP implies
that Bcl-xL, XIAP-Bir3 and XIAP-Bir-1,2 overexpression are not
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Figure 1. Caspase Inhibitors DEVD- and LEHD-FMK Block LTD in CA1 Hippocampal Neurons
Acute hippocampal slices (from 3- to 4-week-old rats) were incubated with caspase inhibitors for 2 hr before recording (DEVD-FMK, 2 mM; LEHD-FMK, 2 mM;
FA-FMK, 10 mM; YVAD-FMK, 5 mM). Extracellular field EPSPs were evoked by stimulating Schaffer collateral CA1 synapses.
(A and B) Effect of DEVD-FMK on LTD and LTP, induced by low frequency stimulation (LFS) and tetanic stimulation (Tet) respectively (control, n = 6; DEVD-FMK,
n = 6).
(C and D) Effect of LEHD-FMK on LTD and LTP (n = 6).
(E and F) Effect of YVAD-FMK or negative control peptide FA-FMK on LTD and LTP (n = 6). Pooled data and example traces are shown in all panels.
Symbols and error bars indicate mean ± SEM. See also Figure S1.nonspecifically inhibiting synaptic function and plasticity. In line
with the pharmacological data, the overexpression experiments
support the idea that activity of caspases -9 and -3/7 are
crucial for LTD. Moreover, the blockade of LTD by Bcl-xL and
XIAP-Bir3 suggests that these caspases are activated by the
mitochondrial pathway.
Loss of LTD in Caspase-3 KO Mice
The pharmacological approach has inherent problems with
specificity, and there are also caveats with overexpression of
proteins such as XIAP, Bcl-xL for several days. For furthercorroboration, we studied synaptic plasticity in caspase-3
knockout mice. In the C57BL/6 background, the homozygous
caspase-3 knockout mice are viable, reach adulthood and
display minimal brain histopathology (Leonard et al., 2002).
LTD and LTP were measured in acute hippocampal slices
taken from caspase-3 knockout (/) mice or wild-type controls
(2–4 weeks age). There was no difference betweenwild-type and
knockout animals with respect to input/output relationship upon
stimulation of Schaffer collateral-CA1 synapses (Figure 3A:
p > 0.05, n = 16), indicating that loss of caspase-3 did not affect
the strength of basal synaptic transmission.Cell 141, 859–871, May 28, 2010 ª2010 Elsevier Inc. 861
Time (min)
0 10 20 30 40 50
N
or
m
al
iz
ed
 p
ea
k 
EP
SC
(%
 of
 ba
se
lin
e)
0
50
100
150
LFS
2 4
31
1 2 1+2 3 4 3+4
100 ms
20
0 
pA
D
Bcl-xL
Control
XIAP-Bir1,2
5 6
Time (min)
0 10 20 30 40 50
N
o
rm
a
liz
ed
 p
ea
k 
EP
SC
(%
 
o
f b
as
el
in
e)
0
50
100
150
LFS
2
43
1
CrmA
XIAP-Bir3
1 2 1+2 3 4 3+4
100 ms
20
0 
pA
E
Time (min)
0 5 10 15 20 25 30
N
o
rm
a
liz
ed
 p
ea
k 
EP
SC
(%
 
o
f b
as
el
in
e)
50
100
150
200
250
2 4
1
5
2 Hz
XIAP-Bir3
Bcl-xL
1 2 1+2 3 4 3+4
100 ms
20
0 
pA
F
XIAP-Bir1,2
5 6 5+6
3 6
5 6 5+6
Transfected EPSCNMDA (pA)
0 100 200 300
Un
tra
ns
fe
ct
ed
 E
PS
C N
M
D
A 
(pA
)
0
100
200
300
Transfected EPSCAMPA (pA)
0 100 200 300 400
Un
tra
ns
fe
ct
ed
 E
PS
C A
M
PA
 
(pA
)
0
100
200
300
400
B
Untransfected cellsTransfected cells
100 ms
10
0 
pA
Transfected EPSCNMDA (pA)
0 100 200 300
Un
tra
ns
fe
ct
ed
 E
PS
C N
M
D
A 
(pA
)
0
100
200
300
Transfected EPSCAMPA (pA)
0 100 200 300 400
Un
tra
ns
fe
ct
ed
 E
PS
C A
M
PA
 
(pA
)
0
100
200
300
400
C
Untransfected cellsTransfected cells
100 ms
10
0 
pA
CrmA
XIAP-Bir1,2
Transfected EPSCNMDA (pA)
0 100 200 300
Un
tra
ns
fe
ct
ed
 E
PS
C N
M
D
A 
(pA
)
0
100
200
300
Transfected EPSCAMPA (pA)
0 100 200 300 400
Un
tra
ns
fe
ct
ed
 E
PS
C A
M
PA
 
(pA
)
0
100
200
300
400
A
Untransfected cellsTransfected cells
100 ms
10
0 
pA
Bcl-xL
Figure 2. Overexpression of Bcl-xL and
XIAP Constructs Blocks LTD in CA1
Neurons of Organotypic Hippocampal Slice
Cultures
CA1 neurons were biolistically transfected with
Bcl-xL, XIAP-Bir1,2, XIAP-Bir3, or CrmA (with
GFP cotransfected as a visual marker) and re-
corded in whole-cell patch-clamp mode.
(A–C) Pairwise analysis of the effects of Bcl-xL (11
pairs of transfected and neighboring untrans-
fected cells), XIAP-Bir1,2 (11 pairs) or CrmA trans-
fection (10 pairs) on basal AMPA-EPSC amplitude
(left graph, recorded at a holding potential of
70mV) and NMDA-EPSC amplitude (right graph,
recorded at a holding potential of +40mV) versus
nearby untransfected cells (pairs of transfected
and neighboring untransfected cells are individu-
ally plotted; black circles). Red symbol and error
bars indicate mean ± SEM. Bcl-xL and XIAP
caused an increased basal EPSCAMPA (rightward
shift on graph) but had no effect on the
EPSCNMDA, in comparison with neighboring un-
transfected cells.
(D) Induction of LTD was blocked in CA1 cells
overexpressing XIAP-Bir1,2 (p > 0.05, n = 7), and
Bcl-xL (p > 0.05, n = 8). LTD was intact in non-
transfected CA1 neurons from organotypic hippo-
campal culture (p < 0.01, n = 6).
(E) LTD induction was blocked by overexpression
of XIAP-Bir3 (n = 8) but not CrmA (n = 8).
(F) LTP was unaffected by overexpression of Bcl-
xL (n = 7), XIAP-Bir1,2 (n = 7) or XIAP-Bir3 proteins
(n = 7).
Graphs show the mean ± SEM.Although it robustly induced synaptic depression in wild-type
hippocampal slices, LFS (1 Hz, 900 pulses) failed to induce LTD
in caspase-3 knockout slices (caspase-3/: 97 ± 6% of base-
line; wild-type: 77 ± 5%, n = 6 slices from 6 animals, p < 0.01;
Figure 3B). The plasticity defect in caspase-3 deficient animals
was specific for LTD, as induction of LTP was remarkably
normal. Two trains of tetanus (100 Hz, 100 pulses) resulted in
LTP that was similar in magnitude in caspase-3 knockout and
wild-type hippocampus (caspase-3/: 154 ± 8% of baseline;
wild-type: 149 ± 3%, n = 6 slices from 6 animals, p > 0.05;
Figure 3C).
The electrophysiological findings in knockout mice indicate
a crucial role for caspase-3 in LTD, consistent with the results
from pharmacological and overexpression experiments.
The expression of AMPA receptors (GluR1 and GluR2) and
NMDA receptors (NR1, NR2A, and NR2B) in caspase-3/
hippocampi was similar to wild-type by immunoblotting
(Figure S2).862 Cell 141, 859–871, May 28, 2010 ª2010 Elsevier Inc.DEVD-FMK and LEHD-FMK Prevent AMPA Receptor
Internalization
The block of LTD by DEVD-FMK and LEHD-FMK suggests that
caspases may regulate the inducible internalization of AMPA
receptors. To test this hypothesis, we measured AMPA receptor
endocytosis in dissociated hippocampal neurons using an ‘‘anti-
body feeding’’ internalization assay (Lee et al., 2002). Treatment
of hippocampal neurons (DIV18) with NMDA (50 mM for 10 min)
stimulated internalization of endogenous AMPA receptors
(Figure 4). The internalization of GluR2 induced by NMDA was
abolished by treatment with DEVD- and LEHD-, but not by
YVAD- or WEHD-FMK (Figures 4A and 4C). DEVD and LEHD
also blocked NMDA-induced internalization of AMPA receptor
GluR1 subunit (Figures 4B and 4C). The basal internalization of
GluR2 (i.e., that occurring in unstimulated neurons) was
unchanged by caspase inhibitors (Figure S3). These data indi-
cate that DEVD- and LEHD-sensitive caspases are specifically
required for the inducible internalization of AMPA receptors.
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Figure 3. LTD Is Abolished in Hippocampal Slices from Caspase-3
Knockout Mice
(A) Input-output relationship in caspase-3/ and wild-type mice (2–4 weeks
age). fEPSP slope was plotted against amplitude of presynaptic volley at
four different stimulus intensities (10 mA, 20 mA, 50 mA and 100 mA). Graph indi-
cates mean ± SEM (p > 0.05, n = 16).
(B) Low frequency stimulation (LFS, 1 Hz, 15 min) failed to induce LTD in cas-
pase-3/ slices (p < 0.01, n = 6).
(C) Magnitude of LTP induced by tetanic stimulation (Tet) was not different
between caspase-3 / and wild-type slices (p > 0.05, n = 6).
See also Figure S2.Bcl-xL, XIAP, and Caspase-3 Knockout Block AMPA
Receptor Internalization
To obtain additional nonpharmacological evidence to support
the importance of caspases in AMPA receptor internalization,
we overexpressed in neurons XIAP, Bcl-xL or CrmA. Transfec-
tion of XIAP-Bir1,2, XIAP-Bir3 or Bcl-xL in hippocampal neurons
prevented NMDA-induced internalization of GluR2 (Figures 5A
and 5C). NMDA-stimulated GluR1 internalization was also in-
hibited by XIAP-Bir1,2, XIAP-Bir3 and Bcl-xL, though not as
completely as for GluR2 (Figures 5B and 5C). In contrast, overex-
pression of CrmA did not significantly reduce NMDA-induced
internalization of GluR2 or GluR1 (Figures 5A–5C). Basal internal-
ization of GluR2 (Figure S4A) and surface expression of GluR2
(Figures S4B and S4C) were unaffected by any of these
constructs. Finally, we found that NMDA-induced GluR2 inter-
nalization was completely abolished in hippocampal neurons
from caspase-3 knockout mice (Figures S4D and S4E).
Together, the molecular genetic and pharmacological data
argue that the activity of caspases-9 and -3/7 is critical for induc-
ible AMPA receptor internalization.
Caspase-7 is expressed at low levels in the brain (Van de
Craen et al., 1997), and we could not detect caspase-7 in rat
brain or cultured neurons by immunoblotting (Figure S4F).
Although we cannot exclude a role for caspase-7, we suppose
that caspase-3 and -9 are probably the main caspases involved
in LTD and AMPA receptor internalization.Transient Activation of Caspase-3 in Neurons by NMDA
Receptor Stimulation
If caspase-3 is involved in LTD and AMPA receptor internaliza-
tion, then caspase-3 should be activated by stimuli that induce
LTD or AMPA receptor endocytosis. To test this possibility, we
measured active caspase-3 by immunoblotting for the cleaved
form of caspase-3 (active caspase-3) (Figure 6). Prolonged
exposure to staurosporine (STS), an inducer of neuronal
apoptosis, caused a delayed but sustained accumulation of
active caspase-3 in cortical neuron cultures (Figures 6A and
6C). At the peak, active caspase-3 was 17-fold higher than in
untreated neurons, and remained > 10-fold elevated for 8 hr.
The NMDA treatment that induced AMPA receptor internaliza-
tion also caused caspase-3 activation, but to a much lower level
than STS and with more rapid and transient kinetics. Caspase-3
activation increased by 33 ± 21% immediately (at 0 min) after
a 10 min treatment with NMDA, although not reaching statistical
significance. Active caspase-3 continued to rise, peaking at30
min after NMDA (213 ± 23% of baseline, n = 4, p < 0.01), beforeCell 141, 859–871, May 28, 2010 ª2010 Elsevier Inc. 863
Figure 4. Caspase Inhibitors DEVD- and
LEHD-FMK Block NMDA-Induced AMPA
Receptor Internalization
Antibody-feeding internalization assay for endog-
enous GluR2 (A) and GluR1 (B) in hippocampal
neurons stimulated with NMDA (50 mM for 10
min). Neurons were pretreated with various cas-
pase inhibitors (5 mM) as indicated. (A) and (B)
show double-label immunostaining for internal-
ized GluR (green, first row) and surface-remaining
GluR (red, second row), and merge (in color, third
row). Individual channels are shown in grayscale.
Quantitation in (C) shows internalization index
(integrated fluorescence intensity of internalized
GluR / integrated fluorescence intensity of inter-
nalized GluR plus surface GluR) normalized to un-
stimulated untreated cells (Lee et al., 2002). For all
quantitations, n = 15 neurons for each group.
*p < 0.05, ***p < 0.001, compared to NMDA
treated cells transfected with b-gal. The graph
shows the mean ± SEM. The scale bar represents
20 mm. See also Figure S3.gradually returning to pretreatment levels (Figures 6A and 6B).
The maximal increase of active caspase-3 after NMDA stimula-
tion was only 2- to 3-fold (cf 10–20 fold for STS) and it864 Cell 141, 859–871, May 28, 2010 ª2010 Elsevier Inc.occurred much more quickly
(Figure 6B). Caspase-9, which lies
upstream of caspase-3 in the mitochon-
drial apoptotic pathway, was also acti-
vated by NMDA stimulation (measured
30 min after NMDA stimulation;
Figure 6D). The activation of caspase-3
and -9 by NMDA was blocked by antag-
onist of NMDA receptors (APV), chela-
tion of extracellular calcium (EGTA)
and inhibitors of intracellular calcium
release (2-APB [IP3 receptor inhibitor]
and dantrolene [ryanodine receptor
inhibitor]) (Figure 6D).
We also measured activation of cas-
pase-3 by an ‘‘in situ’’ binding assay, in
which cultured hippocampal neurons
were labeled with a biotin-conjugated
DEVD probe that has selective affinity
for activated caspase-3/7 (Huesmann
and Clayton, 2006; Thornberry et al.,
1997). The bound biotin-DEVD was
then visualized with Oregon Green-
conjugated NeutrAvidin. In the absence
of stimulation, the level of biotin-DEVD
labeling was low in the cell bodies of
cultured hippocampal neurons (DIV18),
and almost undetectable in dendrites
(Figure S5A, top row). The biotin-DEVD
signal was enhanced by NMDA stimula-
tion and was distributed throughout the
neuron including dendrites (Figure S5A).The DEVD staining in dendrites was often punctate or patchy
in appearance (Figure S5A, insets). We quantified the level of
biotin-DEVD labeling specifically in neuronal dendrites
Figure 5. Antiapoptotic Proteins Inhibit
AMPA Receptor Internalization
Cultured hippocampal neurons (DIV14) were
transfected with Bcl-xL, XIAP-Bir1,2, XIAP-Bir3,
or CrmA, or control b-gal. At 2–4 days after trans-
fection, neurons were treated with NMDA as indi-
cated, and GluR2 (A) and GluR1 internalization (B)
was measured by the antibody-feeding internali-
zation assay, as in Figure 4. (A) and (B) show im-
munostaining for the transfected protein (upper
row), internalized GluR (second row), surface-re-
maining GluR (third row), and merge of internal-
ized and surface GluR (bottom row). All individual
channels of this triple labeling experiment are
shown in grayscale. Arrowheads mark the cell
body of transfected cells. Note that the cell body
of a Bcl-xL transfected neuron in (A) lies adjacent
to an untransfected neuron. Histograms show
internalization index for GluR normalized to unsti-
mulated control-transfected neurons (C). n =
15-30 neurons for each group. ***p < 0.001
(compared to NMDA stimulated b-gal control).
The graph shows mean ± SEM. The scale bar
represents 20 mm. See also Figure S4.
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Figure 6. Transient Activation of Caspase-3 in
Neurons by NMDA
(A, D, and E) Immunoblots showing cleaved (active)
caspase-3 and caspase-9, and cytosolic cytochrome
c in cortical neuronal cultures (DIV18) at various times
after treatment with NMDA (50 mM for 10min) or staur-
osporine (STS, 1 mM throughout the experimental
period). In (D), neurons were preincubated as indi-
cated with 2-APB (30 mM), dantrolene (100 mM), DL-
APV (100 mM) or EGTA (5 mM) for 15 min before
NMDA treatment, and were immunoblotted 30 min
after NMDA stimulation for active (cleaved) and total
caspase-3,-9; and cytochrome c in the cytosolic and
pellet fractions. (B, C, and F) Quantitation (mean ±
SEM) of immunoblot band intensities normalized to
values before treatment (NMDA was applied from
10 to 0 min; STS treatment began at 0 min); n = 3
for each time point. See also Figure S5.(integrated intensity of biotin-DEVD labeling per mm dendrite).
NMDA caused a rapid and transient increase in active cas-
pase-3; active caspase-3 levels rose 44% immediately
following 10 min NMDA treatment and reached a maximum of
2.7-fold at 30 min after NMDA stimulation (Figure S5B). Eight
hours after NMDA treatment, the level of biotin-DEVD staining
was not significantly different from unstimulated neurons
(Figure S5B).
Notably, the increase in biotin-DEVD staining induced by
NMDA (measured at 30 min after NMDA stimulation) was
blocked in neurons transfected with Bcl-xL or XIAP-Bir3
(Figures S5C and S5D; NB the ‘‘beaded’’ pattern of staining
in Bcl-xL and XIAP transfected neurons reflects the subcellular
distribution of the transfected protein, not a toxic effect on the
transfected cells). This result implies that the in situ biotin-
DEVD signal really reflects activation of caspase-3, and it
supports the idea that caspase-3 activation by NMDA is medi-
ated by the mitochondrial pathway. We noted that active cas-
pase-3, as imaged by DEVD-biotin labeling, partially overlap-
ped with Bassoon immunostaining, implying that some
active caspase-3 is present at or close to synapses
(Figure S5E).
The transient time course and low magnitude of caspase-3
activation induced by NMDA suggest that caspase-3 activation
in NMDA-treated neurons may not be involved in cell death. To866 Cell 141, 859–871, May 28, 2010 ª2010 Elsevier Inc.directly assess neuronal death, we stained
cultured hippocampal neurons with propi-
dium iodide (PI) 12 hr after NMDA or staur-
osporine treatment. 77.3% of neurons
treated with staurosporine were positive
for PI staining but there was no increase
in PI staining following NMDA treatment
(% PI-stained cells: untreated, 7.6%;
NMDA, 6.3%). Thus the transient caspase-
3 activation induced by 10 min NMDA stim-
ulation is not associated with eventual
neuronal death, which supports a nonapop-totic role of caspase-3 in AMPA receptor internalization and
synaptic plasticity.
Cytochrome c Release after NMDA Stimulation
The inhibition of LTD by Bcl-xL suggests that during LTD the
caspase-9-caspase-3 cascade is activated by the mitochon-
drial pathway. Bcl-xL inhibits mitochondrial release of proapop-
totic molecules such as cytochrome c. To test whether cyto-
chrome c is released from mitochondria following chemical
LTD, we measured cytochrome c in the cytosolic (mitochon-
dria-free) fraction prepared from cortical neurons by ultracentri-
fugation. Cytochrome c levels in cytosol were almost undetect-
able by immunoblotting in unstimulated cultures, but were
significantly increased in cultures treated with NMDA
(Figure 6E). The level of cytosolic cytochrome c peaked at
10–20 min after NMDA stimulation (Figures 6E and 6F).
COX IV (cytochrome c oxidase subunit IV) was not found in
the cytosol of NMDA-treated neurons (Figure 6E), indicating
lack of contamination with mitochondria. These data show
that NMDA stimulates rapid and transient cytochrome c release
from mitochondria.
Identification of a Caspase-3-Resistant Akt1 Mutant
What is the molecular mechanism by which caspase-3 acts in
LTD? We sought to identify downstream substrates of
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A Figure 7. Overexpression of Caspase-3-
Resistant Triple Mutant of Akt1 Blocks LTD
in CA1 Neurons of Organotypic Hippocampal
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(A) Cleavage of wild-type or mutant Akt1 proteins by
caspase-3 in vitro. In vitro translated WT Akt1,
D108A/D119A/D462N triple mutant or Quadruple
mutant were incubated with increasing amounts of
recombinant active caspase-3 (10, 20, and 40 ng)
at 37C for 18 hr. The caspase-3 inhibitor DEVD-
fmk was either omitted or included in the reactions
containing 40 ng caspase-3. Position of full-length
Akt1 is indicated.
(B) Pairwise analysis of wild-type Akt1 (Akt1) trans-
fected cells and nearby untransfected cells on basal
AMPA receptor-mediated EPSCs (left panel,
EPSCAMPA, recorded at a holding potential of
70mV) and NMDA receptor-mediated EPSCs (right
panel, EPSCNMDA, recorded at +40mV). Red symbols
show mean ± SEM.
(C) Overexpression of WT Akt1 had no effect on LTD
compared to neighboring untransfected cells
(p < 0.01, n = 6).
(D) Pairwise analysis of Akt1triple mutant (D108A/
D119A/D462N)-transfected cells and nearby un-
transfected cells on basal AMPA receptor-mediated
EPSCs and NMDA receptor-mediated EPSCs.
(E) Induction of LTD was blocked in Akt1 triple
mutant transfected cells (p > 0.05, n = 6) but LTD
was intact in neighboring untransfected cells.
(F) LTP was unaffected by overexpression of Akt1
triple mutant.
Graphs show the mean ± SEM. See also Figure S6.caspase-3 that are involved in synaptic plasticity and that would
disrupt LTD when they are rendered resistant to caspase 3-
mediated cleavage. Akt1 is a well-characterized prosurvival
protein kinase and a substrate of caspase-3 during apoptosis
(Bachelder et al., 1999; Widmann et al., 1998). Akt is known to
phosphorylate Ser-9 of glycogen synthase kinase-3b (GSK3b)
and to inhibit the activity of GSK3b, whose function is critical
for LTD (Peineau et al., 2007). Thus, proteolysis and inactivation
of Akt1 by caspase-3 represents a possible mechanism for cas-
pase-3 involvement in LTD.
In order to find a mutant Akt1 that is resistant to caspase-3
cleavage but still functional as a kinase, we characterized a series
ofAkt1mutants thathadsubstitutions inoneormoreof fourputativeCell 141, 859caspase cleavage sites: Asp-108, Asp-119,
Asp-434, and Asp-462 (Rokudai et al., 2000;
Xu et al., 2002) (Figure S6A). These mutant
Akt1 proteins expressed at similar levels to
wild-type Akt1 in HeLa cells (Figure S6B),
and they also showed comparable levels of
phosphorylation at Thr-308 and Ser-473,
which is correlated with activation of Akt1
kinase (FigureS6B). Incontrast, phosphoryla-
tion at Thr-308 and Ser-473 is abolished in
a kinase-defective Akt1 deletion mutant,
Akt1-Mut(1–462) (FigureS6B) (Xuetal., 2002).The Akt1 mutants were characterized for their degree of resis-
tance to caspase cleavage in HeLa cells treated with STS to
induce apoptosis. By immunoblotting, wild-type Akt1 showed
reduced protein levels (50%) at 4 hr after staurosporine addi-
tion, consistent with proteolysis by caspase (Figures S6C and
S6D). Of the Akt1 mutants, only the triple mutant D108A/
D119A/D462N and the quadruple mutant (D108A/D119A/D434/
D462N) showed significantly less drop in levels than wild-type
following STS treatment (Figures S6C and S6D).
To confirm caspase-3 resistance directly, the mutant Akt1
constructs were transcribed and translated in vitro and tested
for proteolysis by purified active recombinant caspase-3
in vitro (Figure 7A). When incubated with caspase-3, wild-type–871, May 28, 2010 ª2010 Elsevier Inc. 867
Akt1 was completely cleaved into shorter polypeptides (includ-
ing a large fragment just slightly shorter than full-length Akt1);
the loss of full-length Akt1 protein was blocked by DEVD-
FMK (Figure 7A). In contrast, the triple mutant Akt1-D108A/
D119A/D462N and the quadruple mutant remained largely
unaltered by caspase-3 (Figure 7A). The other mutant Akt1
proteins were all efficiently cleaved into shorter polypeptides by
caspase-3 (Figure S6E). Thus Asp-108, Asp-119, and Asp-462
in Akt1appear to be the predominant sites for cleavage by
caspase-3.
Finally, we tested in vitro the ability of cleavage-resistant
Akt1 mutants to phosphorylate Ser-9 of GSK3b, a natural
substrate. Akt1 triple mutant D108A/D119A/D462N was as
good as WT Akt1 in phosphorylation of GSK3b Ser-9, but
the quadruple mutant was inactive (Figure S6F). Based on
these data, we identified the triple mutant D108A/D119A/
D462N as an Akt1 mutant that is relatively resistant to cas-
pase-3-mediated proteolysis but retains normal kinase
activity.Caspase-3-Resistant Akt1 Blocks LTD
If Akt1 is a critical substrate of caspase-3 in LTD, then over-
expression of the caspase-3-resistant Akt1 mutant should
block LTD induction. Overexpression of WT Akt1 in CA1 cells
of hippocampal slice cultures caused a slight reduction in
AMPA receptor-mediated EPSCs (WT Akt1: 234 ± 22 pA,
n = 17; untransfected neighboring cells: 310 ± 32 pA,
n = 17, p < 0.05; Figure 7B) and no effect on NMDA
receptor-mediated EPCSs (WT Akt1: 260 ± 27 pA, n = 17;
untransfected: 257 ± 30 pA, n = 17, p > 0.05; Figure 7A).
Induction of LTD, however, was unaffected by overexpression
of WT Akt1 (transfected: 51 ± 8%, n = 6; untransfected: 53 ±
7%, n = 6, p > 0.05; Figure 7C). In cells transfected with the
caspase-3-resistant triple mutant of Akt1 (D108A/D119A/
D462N), both AMPA and NMDA receptor-mediated EPSCs
were significantly increased (triple mutant Akt1 EPSCAMPA:
298 ± 18 pA, n = 17; untransfected: 160 ± 15 pA, n = 17,
p < 0.001; triple mutant Akt1 EPSCNMDA: 221 ± 25 pA,
n = 17; untransfected: 134 ± 11 pA, n = 17, p < 0.001;
Figure 7D). More importantly, LTD was abolished in cells
tranfected with the triple mutant Akt1, while untransfected
cells in the same slice (measured simultaneously in dual
recording conditions) showed normal LTD (triple mutant
Akt1: 98 ± 7%; untransfected: 58 ± 7%, n = 6, p < 0.001;
Figure 7E). There was no difference between transfected
and untransfected cells with respect to LTP (triple mutant
Akt1: 179 ± 24%; untransfected: 176 ± 17%, n = 6,
Figure 7F). These data imply that proteolysis of Akt1 by cas-
pase-3 is necessary for the induction of LTD.
Is Akt1 degraded in hippocampal neurons during chem-LTD?
At 10–20 min post-NMDA stimulation, GluR1 was dephosphory-
lated on Ser-845, as expected; however, there was no measur-
able loss of total Akt1 protein in NMDA-stimulated neuron
cultures by immunoblotting (Figures S6G and S6H). A plausible
explanation for the nondetection of Akt1 degradation is that
only a small fraction of Akt1 is cleaved by caspase-3 locally in
dendrites during chem-LTD.868 Cell 141, 859–871, May 28, 2010 ª2010 Elsevier Inc.DISCUSSION
A Role for Caspases in NMDA Receptor-Dependent LTD
Caspase-3 and caspase-9 are thought to function in neuronal
apoptosis during development, brain trauma and various neuro-
degenerative diseases (Chan and Mattson, 1999; Yuan and
Yankner, 2000). These caspases, as well as apoptosis regulatory
factors such as BAD, BAX, Bcl-xL, and Bcl-2, are expressed in
the mature nervous system, well after the major stage of cell
death in rodent brain development, which occurs during
embryogenesis and the first few postnatal weeks. Although
these proapoptotic molecules could be expressed in the brain
merely to ‘‘prepare’’ neurons for programmed cell death in
response to trauma or disease, it seems plausible that the
molecular pathways used in apoptosis are also exploited in
neurons for purposes other than cell death. This study implicates
the regulators and executors of apoptosis in the molecular
mechanisms of synaptic plasticity.
How does caspase-3 mediate its effects on synaptic depres-
sion? We provide evidence that Akt1 (a known target of cas-
pase-3 during apoptosis (Bachelder et al., 1999; Widmann
et al., 1998)) is a critical substrate of caspase-3 during LTD.
In addition to Akt1, there are likely to be multiple other cas-
pase-3 substrates relevant to synaptic function. Several
synaptic proteins, including GRASP-1 (a GRIP-associated
Ras-guanine nucleotide exchange factor), actin, and AMPA
receptor subunit GluR1, are reported to be cleaved by cas-
pase-3 (Lu et al., 2002; Mashima et al., 1997; Ye et al., 2002).
Caspases may also cleave signaling molecules (e.g., MEKK1,
calcium calmodulin-dependent protein kinase IV) to modify
synaptic strength. That LTD involves degradation of specific
proteins by caspases is an appealing concept, because
synapse weakening is associated with spine shrinkage and
synapse elimination and presumably requires dismantling of ex-
isting postsynaptic structures.
Nonapoptotic Function of Caspases in Synapses
Several lines of evidence argue that caspase-3 and -9 have
specific functional roles in synapses that are unrelated to cell
death. Caspase-3 and -9 are critical for LTD and AMPA receptor
internalization, but not for LTP. If caspase activation inevitably
signals impending cell death, or if caspase inhibitors are nonspe-
cifically toxic to neurons, one would expect less selective effects
on synaptic function. In fact, inhibitors of caspase-3 or -9 should
protect against cell death, rather than cause harm. In addition,
short-term NMDA receptor stimulation that is sufficient to induce
AMPA receptor redistribution and synaptic depression causes
caspase-3 activation that is transient and mild, compared with
a conventional agent (staurosporine) that induces massive
apoptosis. The activation of caspase-3 induced by short-dura-
tion glutamate receptor stimulation was not associated with
increased cell death, implying that caspase-3 activation does
not inevitably lead to cell demise.
Mattson and colleagues have also reported that caspases can
be reversibly activated, and that apoptotic insults such as
trophic factor withdrawal, amyloid beta peptide or staurosporine
can suppress AMPA receptor-mediated responses via a cas-
pase-dependent mechanism (Glazner et al., 2000; Lu et al.,
2002). Bcl-xL overexpression has been reported to enhance
synaptic transmission and synapse number (Li et al., 2008).
It is notable that theMAP kinases p38 and JNK, which arewell-
known players in neuronal apoptosis (Kawasaki et al., 1997;
Yang et al., 1997), have been implicated in synaptic depression
(Zhu et al., 2002, 2005). Recently, Peineu et al. showed that
activity of the protein kinase GSK-3b is increased during, and
critical for, NMDA receptor-dependent LTD (Peineau et al.,
2007). GSK3 is also known to promote cell death, at least in
part via the intrinsic apoptosis pathway (Beurel and Jope,
2006). Interestingly, the prosurvival PI3 kinase-Akt pathway
suppresses GSK3 activity, thereby antagonizing LTD (Peineau
et al., 2007). This idea is in keeping with our finding that
Akt1 needs to be curtailed by caspase-3 proteolysis to allow
for LTD. PP2B/calcineurin—an established player in LTD —is
known to promote apoptosis by dephosphorylating BAD (a proa-
poptotic Bcl-2 family protein), which then activates the mito-
chondrial pathway (Wang et al., 1999). Thus overall, the signaling
mechanisms implicated in LTD are closely linked to those that
regulate cell death and survival.
Mitochondria Involvement in LTD
Mitochondria are well-suited to play a key role in synaptic plas-
ticity. Mitochondria are present in dendrites and occasionally
even in individual spines, and their distribution, morphology
and motility are regulated by synaptic activity (Li et al., 2004).
Mitochondria in dendrites take up Ca2+ after synaptic stimulation
(Pivovarova et al., 2002), and Ca2+ uptake promotes the release
of proapoptotic factors from mitochondria (Pacher and
Hajnoczky, 2001; Szalai et al., 1999). So mitochondria can act
as sensors of elevated postsynaptic Ca2+, which is required for
induction of LTD.
Most dendritic mitochondria span lengths that encompass
multiple synapses. If mitochondrial release of proapoptotic
factors is involved in induction of LTD, one would predict that
LTD is not absolutely synapse-specific. Indeed, LTD tends to
‘‘spread’’ more than LTP (Nishiyama et al., 2000), and heterosy-
naptic LTD (LTD occurring at unstimulated synapses) has been
described in a variety of neurons (Barry et al., 1996; Chevaleyre
and Castillo, 2003; Christie et al., 1995; Scanziani et al., 1996).
Once the apoptotic mechanism is activated, what decides the
balance between synaptic depression versus cell death? We
hypothesize that LTD-inducing stimulation only moderately acti-
vates the mitochondrial apoptotic pathway locally in dendrites,
thereby inducing LTD without ensuing cell death (Gilman and
Mattson, 2002; Lu et al., 2002). The involvement of common
mechanisms in both programmed cell death and synapse
depression/elimination is particularly intriguing because both
these processes are believed to result from competition for
limiting trophic factors.
EXPERIMENTAL PROCEDURES
Electrophysiology of Acute Hippocampal Slices
Standard whole-cell or field recordings were made from hipocampal slices
from Wistar rats (3–4 weeks old) (details in Extended Experimental Proce-
dures). Briefly, field recordings were made from stratum pyramidale in area
CA1. Stimulating electrodes were placed in the Schaffer collateral-commis-
sural pathway. To induce LTP, tetanic stimuli (100 pulses at 100 Hz, 4 trains)were delivered. To induce LTD, low frequency stimulation (LFS; 1 Hz) was
delivered for 200 s at 40 mV holding potential (whole-cell recording) or
900 s (field recordings) to Schaffer collateral-CA1 synapses. EPSC amplitude,
series resistance and input resistance were monitored and analyzed on-line
and off-line using the LTP program (Anderson and Collingridge, 2001). Only
cells with series resistance <25 MU with a change in series resistance <10%
from the start were included.
For caspase-3 knockout experiments, mouse hippocampal slices (350 mm)
were prepared from 2- to 4-week-old mice. 100 Hz stimulation (100 pulses,
2 trains, 30 s interval) was delivered to induce LTP and 1 Hz LFS stimulation
(900 pulses, 15 min) was delivered to induce LTD.
Data were collected from one slice per animal. Data pooled across experi-
ments are expressed as the mean ± SEM and effects of conditioning stimula-
tion weremeasured between 30–35min after induction of LTD and LTP. Statis-
tical significance was calculated by Student’s two-tailed t test.
Hippocampal Slice Culture
Hippocampal slice cultures were prepared from 6- to 8-day-oldWistar rats and
transfected at DIV3-4; whole cell patch recordings of CA1 neurons were per-
formed 3–4 days after transfection (details of methods in Extended Experi-
mental Procedures). To induce LTD, 1 Hz stimulation (200 stimuli) at 40 mV
was delivered. LTPwas induced by pairing 2 Hz stimulation with depolarization
of the postsynaptic cell to 0 mV for 100 s. AMPAR-mediated EPSC amplitude
(EPSCAMPA) was measured as the peak EPSC amplitude at a holding potential
of 70 mV, and NMDAR-mediated EPSC amplitude (EPSCNMDA) was
measured at +40 mV at 50–70 ms after the peak of EPSCAMPA.
Caspase-3 Knockout Mice, DNA Constructs, and Reagents
Caspase-3 knockout mice were purchased from the Jackson Laboratory
(Kuida et al., 1996; Leonard et al., 2002). The following constructs were ob-
tained as gifts: XIAP-Bir3 (Colin S. Duckett, University of Michigan [Wilkinson
et al., 2004]), Bcl-xL (Azad Bonni, HarvardMedical School). Generation of Akt1
constructs, and sources of commercial chemicals and antibodies are
described in Extended Experimental Procedures.
Neuronal Culture and Transfection
Hippocampal neuron cultures were prepared from embryonic day (E) 18–19 rat
embryos (Sala et al., 2001), and grown in Neurobasal medium (Invitrogen) sup-
plemented with 2% B27 (Invitrogen), 0.5 mM glutamine and 12.5 mM gluta-
mate. Neurons were transfected using Lipofectamine 2000 (Invitrogen).
GluR Internalization Assay and Surface Staining
Internalization assays were performed as described (Lee et al., 2002). Briefly,
neurons were incubated with antibodies against the N-terminus of GluR2
(mouse monoclonal, Chemicon) or the N-terminus of GluR1 (rabbit polyclonal,
Calbiochem) for 10 min at 37C, then stimulated with NMDA (50 mM) or left un-
stimulated for 10 min. Neurons were fixed with 4% formaldehyde and 4%
sucrose immediately after the stimulation, and surface-remaining antibody-
labeled GluR was saturated by incubation with Cy5-conjugated secondary
antibody (Jackson ImmunoResearch). Neurons were permeabilized with
methanol (20C), and internalized antibody-labeled GluR was stained with
Alexa 488-conjugated secondary antibody (Invitrogen). To measure steady-
state GluR levels on the cell surface, neurons were incubated with antibodies
against the N-terminus of GluR2 or GluR1 for 10 min at 37C, then fixed with
4% formaldehyde and 4% sucrose and stained with Alexa 488-conjugated
secondary antibody.
Image Acquisition and Image Analysis
Images were acquired using a Zeiss LSM510 confocal microscope with a 633
(NA 1.4) objective. Confocal images were collapsed to make 2D projections.
MetaMorph software was used to measure total integrated intensity of inter-
nalized receptors and surface-remaining receptors in the same region which
includes the cell body and dendrites within50 mmof the cell body. Threshold
was set on the basis of cell-free regions and kept constant for all conditions in
each experiment. Statistical analysis was performed using Student’s t test. All
image acquisition and image analysis were done blind to the treatment.Cell 141, 859–871, May 28, 2010 ª2010 Elsevier Inc. 869
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